AGIOS PHARMACEUTICALS, INC. Common Stock Shares Outstanding

• AGIOS PHARMACEUTICALS, INC. showed an increase of +2.3% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from AGIOS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2013: 3.77 million shares | Q3 2013: 31.07 million shares | Q1 2014: 31.83 million shares | Q2 2014: 34.42 million shares | Q3 2014: 34.64 million shares | Q1 2015: 37.29 million shares | Q2 2015: 37.40 million shares | Q3 2015: 37.61 million shares | Q1 2016: 37.90 million shares | Q2 2016: 38.03 million shares | Q3 2016: 42.01 million shares | Q1 2017: 42.38 million shares | Q2 2017: 48.35 million shares | Q3 2017: 48.62 million shares | Q1 2018: 57.54 million shares | Q2 2018: 57.93 million shares | Q3 2018: 58.17 million shares | Q1 2019: 58.66 million shares | Q2 2019: 58.75 million shares | Q3 2019: 58.88 million shares | Q1 2020: 68.79 million shares | Q2 2020: 69.06 million shares | Q3 2020: 69.20 million shares | Q1 2021: 69.81 million shares | Q2 2021: 59.91 million shares | Q3 2021: 54.72 million shares | Q1 2022: 54.78 million shares | Q2 2022: 54.82 million shares | Q3 2022: 54.89 million shares | Q1 2023: 55.54 million shares | Q2 2023: 55.73 million shares | Q3 2023: 55.88 million shares | Q1 2024: 56.75 million shares | Q2 2024: 56.88 million shares | Q3 2024: 57.02 million shares | Q1 2025: 57.89 million shares | Q2 2025: 58.04 million shares | Q3 2025: 58.28 million shares.
• Over the full 14 years of available data (2012 to 2025), AGIOS PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 1,516.3%.
• Historical annual values: Fiscal year 2025: 58.45 million shares | Fiscal year 2024: 57.16 million shares | Fiscal year 2023: 55.95 million shares | Fiscal year 2022: 55.04 million shares | Fiscal year 2021: 54.33 million shares | Fiscal year 2020: 69.29 million shares | Fiscal year 2019: 68.40 million shares | Fiscal year 2018: 58.22 million shares | Fiscal year 2017: 48.83 million shares | Fiscal year 2016: 42.22 million shares | Fiscal year 2015: 37.70 million shares | Fiscal year 2014: 37.10 million shares | Fiscal year 2013: 31.20 million shares | Fiscal year 2012: 3.62 million shares.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026